|
|
|
|
Molecular Pharmacology, Vol 18, 497-502, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics
-Galactosidase
1 Laboratory of Experimental Pathology, National Cancer Institute, Bethesda, Maryland 20205
An in vitro DNA-directed system for synthesis of
-galactosidase was used to study the
effects of methylnitrosourea (MNU) and ethylnitrosourea (ENU) on function of the DNA
template. Both MNU and ENU inhibited formation of
-galactosidase activity when
added to the complete system at the beginning of incubation; this inhibition increased
with increasing concentrations of either MNU or ENU. When template DNA was exposed
to MNU or ENU before use in the protein synthesis system,
-galactosidase synthesis
was greatly reduced. Under comparable conditions, MNU was more inhibitory than ENU.
Incubation of DNA with MNU or ENU resulted in DNA alkylation, which increased
linearly with the concentration of nitrosourea over the range 0-1% alkylated nucleotides.
MNU was shown to act both as an alkylating agent and, presumably via its degradation
product NCO-, as a carbamoylating agent, but alkylation was far more extensive than
carbamoylation after 10 min at 37°C and pH 8.0. The degree of inhibition of
-galactosidase synthesis was directly related to the extent of total alkylation, irrespective of
whether MNU or ENU was allowed to react with template DNA. No difference in
genotoxicity between these two agents was observed which could be ascribed to differences
in sites of alkylation. Carbamoylation of DNA by exposure to KNCO did not inhibit
synthesis of
-galactosidase, although KNCO was highly inhibitory when added to the
complete system.
Note:
ACKNOWLEDGMENT
The authors would like to thank Mrs. Maxine Bellman for her
excellent help in typing the manuscript.